2pl0: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
We report a clustering of public human protein kinase structures based on, the conformations of two structural elements, the activation segment and, the C-helix, revealing three discrete clusters. One cluster includes, kinases in catalytically active conformations. Each of the other clusters, contains a distinct inactive conformation. Typically, kinases adopt at, most one of the inactive conformations in available X-ray structures, implying that one of the conformations is preferred for many kinases. The, classification is consistent with selectivity profiles of several, well-characterized kinase inhibitors. We show further that inhibitor, selectivity profiles guide kinase classification. For example, selective, inhibition of lck among src-family kinases by imatinib (Gleevec) suggests, that the relative stabilities of inactive conformations of lck are, different from other src-family kinases. We report the X-ray structure of, the lck/imatinib complex, confirming that the conformation adopted by lck, is distinct from other structurally-characterized src-family kinases and, instead resembles kinases abl1 and kit in complex with imatinib. Our, classification creates new paths for designing small-molecule inhibitors., Proteins 2007. (c) 2007 Wiley-Liss, Inc.
We report a clustering of public human protein kinase structures based on the conformations of two structural elements, the activation segment and the C-helix, revealing three discrete clusters. One cluster includes kinases in catalytically active conformations. Each of the other clusters contains a distinct inactive conformation. Typically, kinases adopt at most one of the inactive conformations in available X-ray structures, implying that one of the conformations is preferred for many kinases. The classification is consistent with selectivity profiles of several well-characterized kinase inhibitors. We show further that inhibitor selectivity profiles guide kinase classification. For example, selective inhibition of lck among src-family kinases by imatinib (Gleevec) suggests that the relative stabilities of inactive conformations of lck are different from other src-family kinases. We report the X-ray structure of the lck/imatinib complex, confirming that the conformation adopted by lck is distinct from other structurally-characterized src-family kinases and instead resembles kinases abl1 and kit in complex with imatinib. Our classification creates new paths for designing small-molecule inhibitors. Proteins 2008. (c) 2007 Wiley-Liss, Inc.
 
==Disease==
Known disease associated with this structure: SCID due to LCK deficiency OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=153390 153390]]


==About this Structure==
==About this Structure==
Line 10: Line 13:


==Reference==
==Reference==
Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: Structure of lck/imatinib complex., Jacobs MD, Caron PR, Hare BJ, Proteins. 2007 Oct 1;. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=17910071 17910071]
Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: Structure of lck/imatinib complex., Jacobs MD, Caron PR, Hare BJ, Proteins. 2007 Oct 1;70(4):1451-1460. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=17910071 17910071]
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Non-specific protein-tyrosine kinase]]
[[Category: Non-specific protein-tyrosine kinase]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Jacobs, M.D.]]
[[Category: Jacobs, M D.]]
[[Category: STI]]
[[Category: STI]]
[[Category: kinase phosphorylation]]
[[Category: kinase phosphorylation]]
[[Category: transferase]]
[[Category: transferase]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 12:04:55 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:30:32 2008''

Revision as of 19:30, 21 February 2008

File:2pl0.jpg


2pl0, resolution 2.800Å

Drag the structure with the mouse to rotate

LCK bound to imatinib

OverviewOverview

We report a clustering of public human protein kinase structures based on the conformations of two structural elements, the activation segment and the C-helix, revealing three discrete clusters. One cluster includes kinases in catalytically active conformations. Each of the other clusters contains a distinct inactive conformation. Typically, kinases adopt at most one of the inactive conformations in available X-ray structures, implying that one of the conformations is preferred for many kinases. The classification is consistent with selectivity profiles of several well-characterized kinase inhibitors. We show further that inhibitor selectivity profiles guide kinase classification. For example, selective inhibition of lck among src-family kinases by imatinib (Gleevec) suggests that the relative stabilities of inactive conformations of lck are different from other src-family kinases. We report the X-ray structure of the lck/imatinib complex, confirming that the conformation adopted by lck is distinct from other structurally-characterized src-family kinases and instead resembles kinases abl1 and kit in complex with imatinib. Our classification creates new paths for designing small-molecule inhibitors. Proteins 2008. (c) 2007 Wiley-Liss, Inc.

DiseaseDisease

Known disease associated with this structure: SCID due to LCK deficiency OMIM:[153390]

About this StructureAbout this Structure

2PL0 is a Single protein structure of sequence from Homo sapiens with as ligand. Active as Non-specific protein-tyrosine kinase, with EC number 2.7.10.2 Full crystallographic information is available from OCA.

ReferenceReference

Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: Structure of lck/imatinib complex., Jacobs MD, Caron PR, Hare BJ, Proteins. 2007 Oct 1;70(4):1451-1460. PMID:17910071

Page seeded by OCA on Thu Feb 21 18:30:32 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA